Alzevita is dedicated to empowering early detection and monitoring of Alzheimer's disease through advanced technology. Alzheimer’s is a progressive neurodegenerative disorder that primarily impacts memory, thinking, and behavior. Early identification is essential for managing the disease and slowing its progression, enabling patients and families to plan and receive tailored care
Alzevita,utilize state-of-the-art automated hippocampus segmentation, providing clinicians with consistent, objective assessments to support early diagnosis and continuous monitoring.
Our innovative approach enables healthcare providers to deliver personalized treatments that meet each patient’s unique needs. With Alzevita, aim to make a meaningful difference in the journey of Alzheimer’s care.
Provides precise hippocampal segmentation and volume analysis to support early Alzheimer’s detection.
Reduces manual effort with automated analysis, delivering real-time results for quick decision-making.
Easily integrates into clinical workflows, enhancing efficiency and supporting better patient care.
Timely insights for early intervention in Alzheimer’s care.
AI-based hippocampus segmentation for accurate monitoring.
Detailed hippocampus volume analysis for disease progression.
Minimize the time taken for analysis with an efficient AI backend that processes Images.
Seamless workflows for clinicians and researchers.
